Jbm (Healthcare) Ltd
HKEX:2161
Jbm (Healthcare) Ltd
HKEX:2161
Price:
1.01 HKD
-0.98%
Market Closed
Updated:
May 18, 2024
Jbm (Healthcare) Ltd
Interest Income Expense
|
Jbm (Healthcare) Ltd
Interest Income Expense Peer Comparison
Comparables:
U
3933
1177
C
570
C
3320
HCM
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Jbm (Healthcare) Ltd
HKEX:2161
|
Interest Income Expense
-HK$7.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-64%
|
CAGR 10-Years
N/A
|
|
U
|
United Laboratories International Holdings Ltd
HKEX:3933
|
Interest Income Expense
¥108.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-20%
|
|
|
Sino Biopharmaceutical Ltd
HKEX:1177
|
Interest Income Expense
-¥505.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
C
|
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
|
Interest Income Expense
-¥108m
|
CAGR 3-Years
20%
|
CAGR 5-Years
15%
|
CAGR 10-Years
-21%
|
|
C
|
China Resources Pharmaceutical Group Ltd
HKEX:3320
|
Interest Income Expense
-HK$1.4B
|
CAGR 3-Years
14%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
HUTCHMED (China) Ltd
LSE:HCM
|
Interest Income Expense
$91.3m
|
CAGR 3-Years
4%
|
CAGR 5-Years
30%
|
CAGR 10-Years
23%
|
See Also
What is Jbm (Healthcare) Ltd's Interest Income Expense?
Interest Income Expense
-7.4m
HKD
-7.4m
HKD
Based on the financial report for Mar 31, 2023, Jbm (Healthcare) Ltd's Interest Income Expense amounts to -7.4m HKD.
What is Jbm (Healthcare) Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-64%
-64%
Over the last year, the Interest Income Expense growth was 7%.
You don't have any saved screeners yet
